In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias. Strategies to delay or to reduce dyskinesias are based on the change of levodopa dosing or the early use of dopamine agonists. Dopamine agonists with different pharmacological profile are available. Our paper was aimed to analyse the clinical impact and the management of dyskinesias with dopamine agonists.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372050 | PMC |
| http://dx.doi.org/10.1155/2012/745947 | DOI Listing |
Publication Analysis
Top Keywords
dopamine agonists
12
levodopa-induced dyskinesia
8
clinical aspects
4
aspects management
4
management levodopa-induced
4
dyskinesia parkinson's
4
parkinson's disease
4
disease troublesome
4
troublesome dilemmas
4
dilemmas treatment
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!